Vitharon Boon-Yasidhi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Vitharon Boon-Yasidhi has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
Yuitiang Durier
Division of Infectious Diseases Department of Paediatrics Faculty of Medicine Siriraj Hospital Mahidol University Bangkok Thailand
4 shared publicationsJariya Tarugsa
Division of Child and Adolescent Psychiatry, Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
3 shared publications- Kulkanya Chokephaibulkit
Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
3 shared publications K Chokephaibulkit
Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
2 shared publicationsKulkanya Chokephaibulkit
Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
2 shared publicationsNapat Sittanomai
Division of Child and Adolescent Psychiatry, Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
2 shared publications
Latest Publications
- Open Access
- 1 September 2025
- Published by Wiley in Journal of the International AIDS Society
- Vol. 28 (S5) , e70040
Empowering at‐risk Thai adolescents and young adults: an observational study of “Stand By You” – a person‐centred online service model for HIV self‐screening, text‐based counselling and linkage to care
Introduction: Adolescents and young adults (AYA) are disproportionately at risk of HIV acquisition. Person‐centred online platforms could effectively reach AYA with HIV testing services. We assessed the effectiveness of Stand By You, a mobile application, in delivering HIV‐related services to at‐risk Thai AYAs.Methods: Deidentified data from clients who accessed Stand By You services between August 2022 and February 2024 were analysed. HIV self‐testing (HIVST) services were promoted through TikTok influencers to target AYAs vulnerable to HIV. An automated chatbot provided real‐time responses to client inquiries, and trained counsellors provided confidential, text‐based counselling daily. Clients who completed risk assessments received personalized recommendations for HIVST based on their risk profile. Clients who submitted their HIVST results received post‐test counselling and linkage to care and prophylactic treatment. Multivariable logistic regression was used to assess risk factors for reactive HIVST kit results. The per unit direct cost of the programme's performance metrics were assessed.Results: A total of 8863 clients provided 11,536 risk assessments. The majority were male (76.3%), under the age of 30 (76.0%), identified as members of key populations (60.4%) and first‐time testers (56.1%). Additionally, 27.8% had a history of sexually transmitted infections (3,202/11,536), 16.5% reported receiving money or incentives for sex (1908/11,536) and clients indicated an average of 2.6 sexual partners in the past month (SD 3.4). Out of 7585 submitted HIVST results, 3.6% were reactive (n = 274); 60.2% were linked to care (n = 165/274) and 10.4% are in the process of linkage (n = 23/274). Of the 5.3% invalid results reported (n = 401/7585), nearly all were non‐reactive by the second HIVST (117/187). A history of testing HIV negative (adjusted odds ratio [aOR] 0.54 [95% CI 0.40–0.72], p < 0.001) and receiving pre‐exposure prophylaxis (aOR 0.20 [95% CI 0.06–0.64], p = 0.007) were independently associated with reduced odds of a reactive result. Average direct cost was $18.7, $40.3 and $1100 USD per distributed HIVST kit, first‐time tester and new client linked to care, respectively.Conclusions: AYA populations at risk for HIV can be effectively reached through mobile phone applications that provide services anonymously. Online strategies for HIVST delivery and supportive text‐based counselling can generate high demand, engagement and successful linkage to care.
- 1 September 2025
- Published by Wiley in Journal of the International AIDS Society
- Vol. 28 (S5) , e70040
Open AccessEmpowering at‐risk Thai adolescents and young adults: an observational study of “Stand By You” – a person‐centred online service model for HIV self‐screening, text‐based counselling and linkage to care
Introduction: Adolescents and young adults (AYA) are disproportionately at risk of HIV acquisition. Person‐centred online platforms could effectively reach AYA with HIV testing services. We assessed the effectiveness of Stand By You, a mobile application, in delivering HIV‐related services to at‐risk Thai AYAs.Methods: Deidentified data from clients who accessed Stand By You services between August 2022 and February 2024 were analysed. HIV self‐testing (HIVST) services were promoted through TikTok influencers to target AYAs vulnerable to HIV. An automated chatbot provided real‐time responses to client inquiries, and trained counsellors provided confidential, text‐based counselling daily. Clients who completed risk assessments received personalized recommendations for HIVST based on their risk profile. Clients who submitted their HIVST results received post‐test counselling and linkage to care and prophylactic treatment. Multivariable logistic regression was used to assess risk factors for reactive HIVST kit results. The per unit direct cost of the programme's performance metrics were assessed.Results: A total of 8863 clients provided 11,536 risk assessments. The majority were male (76.3%), under the age of 30 (76.0%), identified as members of key populations (60.4%) and first‐time testers (56.1%). Additionally, 27.8% had a history of sexually transmitted infections (3,202/11,536), 16.5% reported receiving money or incentives for sex (1908/11,536) and clients indicated an average of 2.6 sexual partners in the past month (SD 3.4). Out of 7585 submitted HIVST results, 3.6% were reactive (n = 274); 60.2% were linked to care (n = 165/274) and 10.4% are in the process of linkage (n = 23/274). Of the 5.3% invalid results reported (n = 401/7585), nearly all were non‐reactive by the second HIVST (117/187). A history of testing HIV negative (adjusted odds ratio [aOR] 0.54 [95% CI 0.40–0.72], p < 0.001) and receiving pre‐exposure prophylaxis (aOR 0.20 [95% CI 0.06–0.64], p = 0.007) were independently associated with reduced odds of a reactive result. Average direct cost was $18.7, $40.3 and $1100 USD per distributed HIVST kit, first‐time tester and new client linked to care, respectively.Conclusions: AYA populations at risk for HIV can be effectively reached through mobile phone applications that provide services anonymously. Online strategies for HIVST delivery and supportive text‐based counselling can generate high demand, engagement and successful linkage to care.
- Open Access
- 2 July 2021
- Published by Faculty of Medicine Siriraj Hospital, Mahidol University in Siriraj Medical Journal
- Vol. 73 (7) , 471-477
Social Skills Training Using the Thai Version of UCLA PEERS® in Thai Adolescents with Autism Spectrum Disorder
Objective: To study the feasibility and effectiveness of the Thai version of UCLA PEERS® in Thai adolescents with autism spectrum disorder (ASD).Materials and Methods: The UCLA PEERS® was modified to fit with Thai culture. Twelve adolescents, aged 11-19 years old, with ASD participated in this modified 10-session weekly group intervention during March to October 2015 at Siriraj Hospital, Bangkok, Thailand. Feasibility was assessed by parent satisfaction and session attendance rate. Effectiveness was assessed by social skills improvement rated by parents, Vineland Adaptive Behavior Scales (VABS), the Children’s Depression Inventory (CDI), and the Clinical Global Impression-Improvement Scale (CGI-I).Results: All enrolled participants completed the study. Parents’ satisfaction with the program was 81.92%. The session attendance rates ranged from 83.3 to 100%. At the end of intervention, all of the skills trained in the program were rated as improved by at least half of parents. At 4-month follow-up, all but two skills (entering conversation and handling bullying) were still reported as improved by more than 50% of parents. VABS raw scores significantly increased in the domain of communication (95% confidence interval (CI): -2.25 to -0.89; p=0.036), daily living skills (95% CI: -3.70 to -0.47; p=0.016), and socialization (95% CI: -1.77 to -0.40; p=0.005), and significantly decreased in maladaptive behaviors domain (95% CI: 0.24 to 2.10; p=0.002). Six adolescents had CGI-I scores of very much improved or much improved.Conclusion: The Thai version of UCLA PEERS® is a feasible and effective social skills intervention for Thai adolescents with ASD.
- 2 July 2021
- Published by Faculty of Medicine Siriraj Hospital, Mahidol University in Siriraj Medical Journal
- Vol. 73 (7) , 471-477
Open AccessSocial Skills Training Using the Thai Version of UCLA PEERS® in Thai Adolescents with Autism Spectrum Disorder
Objective: To study the feasibility and effectiveness of the Thai version of UCLA PEERS® in Thai adolescents with autism spectrum disorder (ASD).Materials and Methods: The UCLA PEERS® was modified to fit with Thai culture. Twelve adolescents, aged 11-19 years old, with ASD participated in this modified 10-session weekly group intervention during March to October 2015 at Siriraj Hospital, Bangkok, Thailand. Feasibility was assessed by parent satisfaction and session attendance rate. Effectiveness was assessed by social skills improvement rated by parents, Vineland Adaptive Behavior Scales (VABS), the Children’s Depression Inventory (CDI), and the Clinical Global Impression-Improvement Scale (CGI-I).Results: All enrolled participants completed the study. Parents’ satisfaction with the program was 81.92%. The session attendance rates ranged from 83.3 to 100%. At the end of intervention, all of the skills trained in the program were rated as improved by at least half of parents. At 4-month follow-up, all but two skills (entering conversation and handling bullying) were still reported as improved by more than 50% of parents. VABS raw scores significantly increased in the domain of communication (95% confidence interval (CI): -2.25 to -0.89; p=0.036), daily living skills (95% CI: -3.70 to -0.47; p=0.016), and socialization (95% CI: -1.77 to -0.40; p=0.005), and significantly decreased in maladaptive behaviors domain (95% CI: 0.24 to 2.10; p=0.002). Six adolescents had CGI-I scores of very much improved or much improved.Conclusion: The Thai version of UCLA PEERS® is a feasible and effective social skills intervention for Thai adolescents with ASD.
- 11 February 2021
- Published by SAGE Publications in International Journal of STD & AIDS
- Vol. 32 (4) , 361-367
Disclosure of HIV status to sexual partners among perinatally HIV–infected youth in Thailand
Data regarding disclosure of HIV status to sexual partners among perinatally acquired HIV-infected (PHIV) youth are limited, particularly from Asian countries. This cross-sectional study assessed the patterns of, attitudes about, and factors associated with HIV disclosure to sexual partners among PHIV youth aged 15–24 years who attended a pediatric HIV clinic in Thailand. Participants were interviewed using a semi-structured questionnaire designed to elicit demographic and sexual behavior information. Those who had sexual partners were queried about their relationship and HIV status disclosure. Reasons to disclose or not to disclose were assessed accordingly. Among the 51 (44.4%) youth who had sexual partners, 55.8% had steady partners, 45.1% did not always use condoms, and 41.2% disclosed their HIV status. Reasons to disclose included trust and concern about the risk of infection to their partners. Reasons not to disclose included fear of rejection and stigmatization, and not knowing how to disclose. Most youth reported a need for disclosure-related guidance. Knowing their sexual partner’s HIV status was the only independent factor associated with disclosure (aOR 14.6; 95% CI 2.8–75.4). This study demonstrates a high rate of unsafe sex and a low rate of partner disclosure in PHIV youth, and highlights the need for a comprehensive guideline for HIV disclosure to sexual partners.
- 11 February 2021
- Published by SAGE Publications in International Journal of STD & AIDS
- Vol. 32 (4) , 361-367
Disclosure of HIV status to sexual partners among perinatally HIV–infected youth in Thailand
Data regarding disclosure of HIV status to sexual partners among perinatally acquired HIV-infected (PHIV) youth are limited, particularly from Asian countries. This cross-sectional study assessed the patterns of, attitudes about, and factors associated with HIV disclosure to sexual partners among PHIV youth aged 15–24 years who attended a pediatric HIV clinic in Thailand. Participants were interviewed using a semi-structured questionnaire designed to elicit demographic and sexual behavior information. Those who had sexual partners were queried about their relationship and HIV status disclosure. Reasons to disclose or not to disclose were assessed accordingly. Among the 51 (44.4%) youth who had sexual partners, 55.8% had steady partners, 45.1% did not always use condoms, and 41.2% disclosed their HIV status. Reasons to disclose included trust and concern about the risk of infection to their partners. Reasons not to disclose included fear of rejection and stigmatization, and not knowing how to disclose. Most youth reported a need for disclosure-related guidance. Knowing their sexual partner’s HIV status was the only independent factor associated with disclosure (aOR 14.6; 95% CI 2.8–75.4). This study demonstrates a high rate of unsafe sex and a low rate of partner disclosure in PHIV youth, and highlights the need for a comprehensive guideline for HIV disclosure to sexual partners.
- 30 March 2015
- Published by SAGE Publications in International Journal of STD & AIDS
- Vol. 27 (4) , 288-295
Effect of HIV diagnosis disclosure on psychosocial outcomes in Thai children with perinatal HIV infection
A provider-assisted, counselling-based, paediatric HIV disclosure model was developed and implemented at two tertiary-care hospitals in Bangkok, Thailand. All undisclosed perinatally acquired HIV-infected children, aged 7–18 years, and their caretakers were offered the four-step disclosure service, including: screening, readiness assessments and preparation, disclosure sessions, and follow-up evaluations. To assess psychosocial outcomes of disclosure, we compared the scores of the Children Depression Inventory and the PedsQL 4.0™ at baseline and at two-month and six-month follow-up visits, and compared the scores of the Child Behavioral Checklist at baseline and at six-month follow-up. Disclosure was made to 186 children, 160 of whom completed post-disclosure assessments. The median Children’s Depression Inventory score in 135 children decreased significantly from 11 at baseline to 8 at two-month and six-month follow-up (p < 0.01). The median PedsQL 4.0™ scores in 126 children increased significantly from 78 at baseline to 80 at two-month and 84 at six-month follow-up (p = 0.04). The median Child Behavioral Checklist scores were not significantly changed. In conclusion, paediatric HIV diagnosis disclosure using this model was found to have positive effect on the children’s mood and quality of life, and no negative effect on children’s behaviours. This disclosure programme should be expanded to improve the psychosocial health of HIV-infected children.
- 30 March 2015
- Published by SAGE Publications in International Journal of STD & AIDS
- Vol. 27 (4) , 288-295
Effect of HIV diagnosis disclosure on psychosocial outcomes in Thai children with perinatal HIV infection
A provider-assisted, counselling-based, paediatric HIV disclosure model was developed and implemented at two tertiary-care hospitals in Bangkok, Thailand. All undisclosed perinatally acquired HIV-infected children, aged 7–18 years, and their caretakers were offered the four-step disclosure service, including: screening, readiness assessments and preparation, disclosure sessions, and follow-up evaluations. To assess psychosocial outcomes of disclosure, we compared the scores of the Children Depression Inventory and the PedsQL 4.0™ at baseline and at two-month and six-month follow-up visits, and compared the scores of the Child Behavioral Checklist at baseline and at six-month follow-up. Disclosure was made to 186 children, 160 of whom completed post-disclosure assessments. The median Children’s Depression Inventory score in 135 children decreased significantly from 11 at baseline to 8 at two-month and six-month follow-up (p < 0.01). The median PedsQL 4.0™ scores in 126 children increased significantly from 78 at baseline to 80 at two-month and 84 at six-month follow-up (p = 0.04). The median Child Behavioral Checklist scores were not significantly changed. In conclusion, paediatric HIV diagnosis disclosure using this model was found to have positive effect on the children’s mood and quality of life, and no negative effect on children’s behaviours. This disclosure programme should be expanded to improve the psychosocial health of HIV-infected children.
- Open Access
- 18 November 2014
- Published by Wiley in International Scholarly Research Notices
- Vol. 2014, 1-4
Assessing Child Maltreatment in Children Born to Mothers Who Used Methamphetamine during Pregnancy at Siriraj Hospital, Bangkok, Thailand: A Pilot Study
Studies on maltreatment of children born to methamphetamine abusing mothers are lacking. This cross-sectional study examined child maltreatment among children born at Siriraj Hospital, Bangkok, Thailand, to mothers who used methamphetamines during pregnancy. During the study period between July 2011 and January 2012, 34 caretakers of these children were interviewed using the ISPCAN Child Abuse Screening Tool-Parent Version (ICAST-P) to assess their disciplinary actions. The associations between child’s and caretaker’s characteristics and child maltreatment behaviors were analyzed. More than 90% of caretakers were female with age ranging from 18 to 35 years and about 60% were biological mothers. The children’s age ranged from 1 to 9 years. Disciplinary acts and child rearing practices that were considered to be child maltreatment behaviors were reported as follows: psychological discipline 82.4%, physical discipline 79.4%, and neglect 29.4%. No associations between the child’s or the caretaker’s characteristics and child maltreatment behaviors were found. In conclusion, child maltreatment behaviors were frequent in caretakers of children born to mothers who used methamphetamine during pregnancy. Supervision on child rearing and careful monitoring are needed for this population.
- 18 November 2014
- Published by Wiley in International Scholarly Research Notices
- Vol. 2014, 1-4
Open AccessAssessing Child Maltreatment in Children Born to Mothers Who Used Methamphetamine during Pregnancy at Siriraj Hospital, Bangkok, Thailand: A Pilot Study
Studies on maltreatment of children born to methamphetamine abusing mothers are lacking. This cross-sectional study examined child maltreatment among children born at Siriraj Hospital, Bangkok, Thailand, to mothers who used methamphetamines during pregnancy. During the study period between July 2011 and January 2012, 34 caretakers of these children were interviewed using the ISPCAN Child Abuse Screening Tool-Parent Version (ICAST-P) to assess their disciplinary actions. The associations between child’s and caretaker’s characteristics and child maltreatment behaviors were analyzed. More than 90% of caretakers were female with age ranging from 18 to 35 years and about 60% were biological mothers. The children’s age ranged from 1 to 9 years. Disciplinary acts and child rearing practices that were considered to be child maltreatment behaviors were reported as follows: psychological discipline 82.4%, physical discipline 79.4%, and neglect 29.4%. No associations between the child’s or the caretaker’s characteristics and child maltreatment behaviors were found. In conclusion, child maltreatment behaviors were frequent in caretakers of children born to mothers who used methamphetamine during pregnancy. Supervision on child rearing and careful monitoring are needed for this population.
- 5 March 2014
- Published by SAGE Publications in International Journal of STD & AIDS
- Vol. 25 (13) , 929-935
Factors associated with caretaker’s readiness for disclosure of HIV diagnosis to HIV-infected children in Bangkok, Thailand
Summary To determine factors associated with caretaker’s readiness to disclose an HIV diagnosis to their child, a prospective study was conducted among caretakers of HIV-infected children aged seven to 16 years who were receiving care at two paediatric HIV treatment centres in Bangkok. Caretakers were offered readiness preparation counselling and their perceptions on disclosure were assessed using a semi-structured questionnaire. Among caretakers who had participated in the readiness preparation process for at least one year, 71% (195/273) were ready for disclosure. Using logistic regression analysis, we found that child’s age of nine years or older, child’s severe immunosuppression, caretakers having prior discussion with their child about the illness, caretaker’s perception that their child had the ability to understand the HIV diagnosis and to keep it secret, and caretaker’s opinion that the proper age for disclosure is between seven and 12 years old were associated with caretaker’s readiness for disclosure. These determinants may be useful for guiding disclosure readiness preparation counselling.
- 5 March 2014
- Published by SAGE Publications in International Journal of STD & AIDS
- Vol. 25 (13) , 929-935
Factors associated with caretaker’s readiness for disclosure of HIV diagnosis to HIV-infected children in Bangkok, Thailand
Summary To determine factors associated with caretaker’s readiness to disclose an HIV diagnosis to their child, a prospective study was conducted among caretakers of HIV-infected children aged seven to 16 years who were receiving care at two paediatric HIV treatment centres in Bangkok. Caretakers were offered readiness preparation counselling and their perceptions on disclosure were assessed using a semi-structured questionnaire. Among caretakers who had participated in the readiness preparation process for at least one year, 71% (195/273) were ready for disclosure. Using logistic regression analysis, we found that child’s age of nine years or older, child’s severe immunosuppression, caretakers having prior discussion with their child about the illness, caretaker’s perception that their child had the ability to understand the HIV diagnosis and to keep it secret, and caretaker’s opinion that the proper age for disclosure is between seven and 12 years old were associated with caretaker’s readiness for disclosure. These determinants may be useful for guiding disclosure readiness preparation counselling.
- Open Access
- 3 February 2014
- Published by Wiley in Psychiatry Journal
- Vol. 2014, 1-4
Adverse Effects of Risperidone in Children with Autism Spectrum Disorders in a Naturalistic Clinical Setting at Siriraj Hospital, Thailand
A cross-sectional study was conducted to evaluate adverse effects associated with risperidone in 45 children with autism spectrum disorders (ASD), aged 2–15 years, who were treated at Siriraj Hospital, Thailand, between the years 2006 and 2007. Adverse effects were assessed by parent interview, using a semistructure questionnaire, and medical records review. The mean ± SD age of the children at starting risperidone wasyears. The mean ± SD of risperidone dose was mg/day and the mean ± SD duration of treatment wasmonths. Adverse effects were reported in 39 children (86.7%). Common adverse effects included increased appetite, somnolence, and rhinorrhea and most of the adverse effects were tolerable. Tardive dyskinesia or other serious adverse events were not found in this study. The child’s mean ± SD weight gain was kg/year, which exceeded developmentally expected norms. The results from this study suggest that risperidone treatment in children with ASD is associated with frequent mild and tolerable adverse effects. However, excessive weight gain could be found to be a concerning adverse effect and weight monitoring is warranted when risperidone is being prescribed.- 3 February 2014
- Published by Wiley in Psychiatry Journal
- Vol. 2014, 1-4
Open AccessAdverse Effects of Risperidone in Children with Autism Spectrum Disorders in a Naturalistic Clinical Setting at Siriraj Hospital, Thailand
A cross-sectional study was conducted to evaluate adverse effects associated with risperidone in 45 children with autism spectrum disorders (ASD), aged 2–15 years, who were treated at Siriraj Hospital, Thailand, between the years 2006 and 2007. Adverse effects were assessed by parent interview, using a semistructure questionnaire, and medical records review. The mean ± SD age of the children at starting risperidone wasyears. The mean ± SD of risperidone dose was mg/day and the mean ± SD duration of treatment wasmonths. Adverse effects were reported in 39 children (86.7%). Common adverse effects included increased appetite, somnolence, and rhinorrhea and most of the adverse effects were tolerable. Tardive dyskinesia or other serious adverse events were not found in this study. The child’s mean ± SD weight gain was kg/year, which exceeded developmentally expected norms. The results from this study suggest that risperidone treatment in children with ASD is associated with frequent mild and tolerable adverse effects. However, excessive weight gain could be found to be a concerning adverse effect and weight monitoring is warranted when risperidone is being prescribed. - 8 May 2013
- Published by Taylor & Francis in AIDS Care
- Vol. 25 (6) , 756-762
Development of a diagnosis disclosure model for perinatally HIV-infected children in Thailand
While disclosure of HIV status to perinatally HIV-infected children has become an increasingly important clinical issue, specific disclosure guidelines are lacking. We developed a pediatric HIV diagnosis disclosure model to support caretakers. All HIV-infected children greater than 7-years-old at two participating hospitals in Bangkok, Thailand, and their caretakers, were offered disclosure according to the 4-step protocol: (1) screening; (2) readiness assessment; (3) disclosure; and (4) follow-up. Disclosure occurred after agreement of both providers and caretakers. Among 438 children who were screened, 398 (89%) were eligible. Readiness assessment was completed for 353 (91%) of eligible children and 216 (61%) were determined ready. Disclosure was done for 186 children. The mean age at eligibility screening was 10.5 years (range: 6.8–15.8 years); the mean age at disclosure was 11.7 years (range: 7.6–17.7 years). The mean duration between eligibility screening and disclosure was 15.2 months. There were no significant negative behavioral or emotional outcomes reported in children following disclosure. This HIV diagnosis disclosure model was feasible to implement and had no negative outcomes. As the time for preparation process was over 1 year for most cases, the disclosure process can be initiated as early as age 7 to allow enough time for disclosure to be completed by the age of adolescence.
- 8 May 2013
- Published by Taylor & Francis in AIDS Care
- Vol. 25 (6) , 756-762
Development of a diagnosis disclosure model for perinatally HIV-infected children in Thailand
While disclosure of HIV status to perinatally HIV-infected children has become an increasingly important clinical issue, specific disclosure guidelines are lacking. We developed a pediatric HIV diagnosis disclosure model to support caretakers. All HIV-infected children greater than 7-years-old at two participating hospitals in Bangkok, Thailand, and their caretakers, were offered disclosure according to the 4-step protocol: (1) screening; (2) readiness assessment; (3) disclosure; and (4) follow-up. Disclosure occurred after agreement of both providers and caretakers. Among 438 children who were screened, 398 (89%) were eligible. Readiness assessment was completed for 353 (91%) of eligible children and 216 (61%) were determined ready. Disclosure was done for 186 children. The mean age at eligibility screening was 10.5 years (range: 6.8–15.8 years); the mean age at disclosure was 11.7 years (range: 7.6–17.7 years). The mean duration between eligibility screening and disclosure was 15.2 months. There were no significant negative behavioral or emotional outcomes reported in children following disclosure. This HIV diagnosis disclosure model was feasible to implement and had no negative outcomes. As the time for preparation process was over 1 year for most cases, the disclosure process can be initiated as early as age 7 to allow enough time for disclosure to be completed by the age of adolescence.
- Open Access
- 22 August 2010
- Published by Springer Nature in Quality of Life Research
- Vol. 19 (10) , 1509-1516
Health-related Quality of Life of Thai children with HIV infection: a comparison of the Thai Quality of Life in Children (ThQLC) with the Pediatric Quality of Life Inventory™ version 4.0 (PedsQL™ 4.0) Generic Core Scales
- 22 August 2010
- Published by Springer Nature in Quality of Life Research
- Vol. 19 (10) , 1509-1516
Open AccessHealth-related Quality of Life of Thai children with HIV infection: a comparison of the Thai Quality of Life in Children (ThQLC) with the Pediatric Quality of Life Inventory™ version 4.0 (PedsQL™ 4.0) Generic Core Scales
- 1 November 2005
- p. S156-62
An open-label, prospective study of guanfacine in children with ADHD and tic disorders.
To evaluate the efficacy and safety of guanfacine in children with attention-deficit hyperactivity disorder (ADHD) and tic disorders. Twenty-five medication-free subjects (23 males and 2 females), aged 7-16 (mean = 10.6 +/- 2.0) years participated in an 8-week open-label guanfacine study. Subjects were recruited from a specialty clinic for children with tic disorders over a four-year period. Eligibility criteria included presence of ADHD (any type), a tic disorder (any type), and being medication free for two weeks. Outcome measures included the Hyperactivity Index of the Conners Parent Questionnaire, the teacher-rated ADHD Rating Scale, and the Yale Global Tic Severity Scale (YGTSS). All subjects met criteria for ADHD (combined type N = 22; predominantly inattentive type N = 3) and a tic disorder (Tourette's Disorder N = 20; chronic motor tic disorder N = 5). At an average dose of 2.0 +/- 0.6 mg/ day, guanfacine was associated with mean improvement of 27% on the Hyperactivity Index (N = 25; t = 4.61; p < 0.001), 32% on the total score of the teacher-rated ADHD Scale (N = 19; t = 5.27; p < 0.001), and 39% on the total tic severity scale (N = 19; t = 4.17; p < 0.001). Mild and statistically insignificant decreases in blood pressure and pulse were observed in the sample as a whole. Five subjects had endpoint systolic blood pressure below 1 SD from their age and gender norms. Results of this open-label study add to the growing data base on the safety and efficacy of guanfacine in children with ADHD and tic disorders.
- 1 November 2005
- p. S156-62
An open-label, prospective study of guanfacine in children with ADHD and tic disorders.
To evaluate the efficacy and safety of guanfacine in children with attention-deficit hyperactivity disorder (ADHD) and tic disorders. Twenty-five medication-free subjects (23 males and 2 females), aged 7-16 (mean = 10.6 +/- 2.0) years participated in an 8-week open-label guanfacine study. Subjects were recruited from a specialty clinic for children with tic disorders over a four-year period. Eligibility criteria included presence of ADHD (any type), a tic disorder (any type), and being medication free for two weeks. Outcome measures included the Hyperactivity Index of the Conners Parent Questionnaire, the teacher-rated ADHD Rating Scale, and the Yale Global Tic Severity Scale (YGTSS). All subjects met criteria for ADHD (combined type N = 22; predominantly inattentive type N = 3) and a tic disorder (Tourette's Disorder N = 20; chronic motor tic disorder N = 5). At an average dose of 2.0 +/- 0.6 mg/ day, guanfacine was associated with mean improvement of 27% on the Hyperactivity Index (N = 25; t = 4.61; p < 0.001), 32% on the total score of the teacher-rated ADHD Scale (N = 19; t = 5.27; p < 0.001), and 39% on the total tic severity scale (N = 19; t = 4.17; p < 0.001). Mild and statistically insignificant decreases in blood pressure and pulse were observed in the sample as a whole. Five subjects had endpoint systolic blood pressure below 1 SD from their age and gender norms. Results of this open-label study add to the growing data base on the safety and efficacy of guanfacine in children with ADHD and tic disorders.